Company Profile
Sector
HealthcareIndustry
BiotechnologyEmployees
N/AWebsite
www.biogend.comCountry
TaiwanExchange
Taipei ExchangeFounded 2016
BioGend Therapeutics provides the research and development, and sale of orthopedic medical devices and related products. The company offers RevoCart, an autologous cartilage repair system; and SoufCut, an autologous adipose tissue collection system.
It develops BiG-001, an osteoinductive bone graft substitute. Its portfolio also includes BiG-006 for lumbar interbody fusion, and BiG-009, an autologous cartilage repair system for articaular cartilage. The company operates in Taiwan, Hongkong, Chinese Mainland, and Malaysia. Founded in 2016, BioGend Therapeutics is based in Taipei, Taiwan.